BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Elekta and BrainLAB AG Collaborate to Increase Accuracy and Comfort of Radiosurgery Treatments for Individuals with Cancer


7/30/2012 9:38:37 AM

FELDKIRCHEN, Germany, July 30, 2012 /PRNewswire/ -- Cancer management technology leaders, Brainlab and Elekta announced the first installation of an Elekta linear accelerator (linac) equipped with ExacTrac® Patient Positioning system by Brainlab; a strategy to make radiosurgery treatments for cancer patients more accurate and comfortable. ExacTrac is planned to be integrated with a total of two Elekta linacs at Fortis Memorial Research Institute in Gurgaon, India.

"ExacTrac is a highly accurate, intuitive and fast IGRT system and, in combination with our advanced Elekta treatment system, gives us the opportunity to maximize the benefits of both systems for our patients," says Dr. Ashok V. Chordiya, Zonal Director, Fortis Memorial Research Institute, Gurgaon.

With more than 500 installations worldwide, ExacTrac is a field-proven system for supporting sub-millimetric patient positioning for patients with tumors anywhere in the brain and body. The system offers a valuable solution, known as Frameless Radiosurgery. ExacTrac helps to reduce errors within the treatment process and potentially maximize overall accuracy.

"In our search to advance the accessibility to high precision treatment alternatives that are less invasive, we required collaboration with an equally dedicated partner," commented Thomas Kraft, President RoW/Japan, Brainlab. "In Elekta, we found such a partner, and one with a highly regarded, advanced treatment platform. Together we will continue to strive for optimal efficiency, integrated workflow and improved patient care."

Bill Yaeger, Executive Vice President of Elekta Oncology, commented:

"We believe that technology should be based on open interfaces and industry standards, since hospitals use different kinds of technical solutions. ExacTrac will give customers the freedom to choose a solution that best meets their unique workflow and patient care needs. The stereotactic workflow between both systems allows an accurate and fast workflow for patient positioning."

Fortis Healthcare Ltd., with an asset-base spanning ten countries, is a leading, integrated healthcare provider in the Pan Asia-Pacific region. The installation of the combined linac denotes their dedication to continued advancement of the healthcare sector.

About Brainlab

Brainlab develops, manufactures and markets software-driven medical technology with the aim of optimizing patient treatments. Core products revolve around less-invasive image guided surgery technology, more accurate and effective radiation therapy, and integration through planning and collaboration systems that brings patient data and physicians together. www.brainlab.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

® Registered trademark of Brainlab in Germany and the US

Press enquiries to:

Jennifer Agnew
Account Supervisor
D +1 323 762 2417
M +1 323 240 4847
jennifer.agnew@porternovelli.com
porternovelli.com

SOURCE Brainlab



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->